Notícias

OpenAI plans a screen-free AI home device while Apple seeks an injunction that could delay its rollout.

OpenAI still plans a year-end device reveal, but Apple's lawsuit, ecosystem strength and rising component costs may complicate its hardware push.

July 15 () - Shares of Celcuity fell about 8% in premarket trading on Wednesday, as the delayed commercial launch ‌of its newly approved breast cancer drug and treatment-tolerability ‌concerns overshadowed the company's first U. Food and Drug Administration on ​Tuesday approved gedatolisib, branded as Revtorpyk, for certain patients with advanced breast cancer whose tumors do not carry a PIK3CA mutation.

Just one day after glowing reviews, a surprise revenue warning sent the stock into a tailspin and brought lawyers to the door.

Still, shares fell by nearly 20% after the company revealed a delay in the coming launch of Revtorpyk. Details in the drug’s prescribing information surprised some analysts, too.

Alphabet unit Google on Wednesday urged Europe's top court to dismiss EU antitrust regulators' appeal ‌against a lower court ruling that scrapped a €1.49 billion ($1.7 billion) fine, saying ‌the regulators' arguments were flawed. The dispute reached the Court of Justice of the European Union ​after regulators appealed a 2024 General Court ruling that annulled the fine imposed on Google in 2019. The lower court cited errors in the European Commission's assessment of the case.

The primary reason for the 12-state lawsuit is that a Paramount-WBD combination would curb entertainment content and distribution, putting the TV/movie marketplace into fewer hands. What's the fallout?

The product is expected to be OpenAI’s first physical AI device and a crucial milestone as the company moves forward with its IPO plans.

The U.S. Department of Justice has expanded an antitrust investigation to include UnitedHealth Group's Claritev unit. The Claritev review is part of broader DOJ scrutiny of healthcare industry practices and market competition. This development adds a fresh layer of regulatory attention for UnitedHealth Group (NYSE:UNH) beyond routine oversight. UnitedHealth Group, one of the largest managed care and healthcare services companies in the U.S., spans insurance, care delivery, and data-driven...

OpenAI has issued another statement on the lawsuit, this time suggesting it lacks merit.

Apple seeks damages and other legal remedies that could slow OpenAI's device development and hiring.

OpenAI says it takes Apple’s complaint seriously but questions whether the allegations have any merit.

Gedatolisib, in-licensed from Pfizer in 2021, is Celcuity’s sole late-stage asset.

There’s no sugarcoating it; getting laid off is awful. But if you've been following the news, it feels like tech workers are being laid off left and right. Here’s what one Reddit user, who was recently laid off from an account executive role at a tech company, had to say on the r/Layoffs subreddit: ...

This deal could seriously harm movie theatres.

Eli Lilly and Company (LLY) on Tuesday received traditional approval from the US Food and Drug Admin

(Updates with Claritev's response in the fourth paragraph.) The US Justice Department recently se

Hachette, Cengage, Elsevier, and other publishers allege that Google trained its AI on copyrighted works without the necessary permissions.

(Update with the Justice Department's response to a request for comment in the third paragraph.)

Plaintiffs allege Meta's AI-assisted evaluation process was discriminatory.

Apple's lawsuit against OpenAI shows how important AI devices will be for the iPhone maker.

Stock Market Today: The Dow Jones index dropped Tuesday ahead of the June CPI inflation report. IBM stock plunged 23% on earnings.

Apple hit an all-time stock high after it filed one of its most aggressive lawsuits in years, and the market barely flinched. That disconnect between price and risk is exactly what most investors are not pricing in right now.

Carr expressed his views on the Paramount-Warner Bros. Discovery merger, antitrust concerns and Disney’s DEI-related investigations.

Apple almost never sues, so when Tim Cook personally greenlit a complaint accusing OpenAI of stealing trade secrets and smuggling hardware prototypes out the door, Wall Street and Silicon Valley both took notice. The question now is whether the case disrupts OpenAI's IPO plans before a single share is priced.

‘The bad blood between Apple and OpenAI plays into Google’s hands,’ says Paul Meeks, head of technology research at Freedom Capital Markets.

Public dispute escalates as Apple sues OpenAI and Musk renews criticism while defending SpaceX's AI infrastructure plans.

The lawsuit, which accuses OpenAI of stealing Apple’s hardware and trade secrets, marks a dramatic turn for two companies that were close partners.

The two billionaires exchanged barbs on X over Apple's allegations that OpenAI is stealing operational secrets related to Apple's proprietary hardware.

Navitas is facing intense scrutiny as Wolfspeed filed a patent infringement lawsuit against it. How should you play Navitas now?